XML 32 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
OPERATING ACTIVITIES      
Net income $ 98,708 $ 113,641 $ 123,366
Adjustments to reconcile to cash from operations:      
Depreciation 125,709 123,130 121,401
Amortization 10,787 11,557 12,624
Stock-based compensation expense 22,115 24,340 24,657
Restructuring and other charges, net (Note 16) 11,813 12,152 4,106
Deferred Income Tax Expense (Benefit) (13,084) (8,017) (9,219)
Insurance Recoveries (12,100)    
Gain on divestiture (Note 4) 1,512 0 0
Changes in certain assets and liabilities:      
Accounts receivable 9,068 (2,624) (11,543)
Inventories (17,396) 36,835 17,582
Accounts payable and accrued liabilities (6,157) (6,086) (32,514)
Accrued income taxes (12,267) (16,219) 852
Accrued pension and postretirement benefits (7,393) (9,481) (10,103)
Other (5,039) (3,525) 9,657
Net cash flow provided by operating activities 208,324 277,108 257,945
INVESTING ACTIVITIES      
Payments to Acquire Productive Assets 88,971 107,561 94,385
Disposals of property, plant and equipment 1,841 5,425 5,029
Proceeds from divestiture (Note 4) 18,689 0 0
Proceeds from Insurance Settlement, Investing Activities 11,793    
Payments to Acquire Businesses, Net of Cash Acquired 0 (4,010) 0
Other (5,177) (3,280) 126
Net cash flow used for investing activities (61,825) (109,426) (89,230)
FINANCING ACTIVITIES      
Net (decrease) increase in notes payable (459) 714 (1,270)
Net (decrease) increase in revolving and other lines of credit 0 0 (19,000)
Purchase of capital stock (60,120) (65,574) (49,290)
The effect of employee benefit and stock plans and dividend reinvestment (7,059) (9,982) (6,042)
Cash dividends paid to Shareholders (61,852) (63,431) (64,524)
Other (4,429) (3,474) (2,982)
Net cash flow used for financing activities (133,919) (141,747) (143,108)
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation (11) (3,985) (5,172)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12,569 21,950 20,435
CASH AND CASH EQUIVALENTS      
Cash and cash equivalents, beginning of year 127,971 106,021 85,586
Cash and cash equivalents, end of year   127,971 106,021
Cash and cash equivalents 140,540 127,971 106,021
Other Noncash Income (Expense) $ 2,048 $ 1,405 $ 7,079